Document Classification

Section Type: RESULTS

Text: In the ITT : S/M = F analysis at Week 48, a greater proportion of ABC/COM-treated patients achieved HIV-1 RNA < 400 copies/mL (66 % [109/164] vs. 50 % [82/165] ; treatment difference 16. 6 %, 95 % CI (6. 0, 27. 2), p = 0. 002) and HIV-1 RNA < 50 copies/mL (60 % [99/164] vs. 50 % [83/165] ; treatment difference 9. 6 %, 95 % CI [-1. 1, 20. 2]), whereas the AT analysis showed similar proportions achieving these endpoints (< 400 copies/mL : 85 vs. 83 % ; < 50 copies/mL : 79 vs 81 %).